Skip to main content

Table 2 Mean (±standard error) estimates derived from mixed model repeated measures (MMRM, unadjusted estimates) comparing differences between the dietary support (DS) and social support (SS) groups in terms of changes from baseline to primary endpoint of 12 weeks

From: A randomised controlled trial of dietary improvement for adults with major depression (the ‘SMILES’ trial)

Characteristic

DS

SS

Between-group differences in change from baseline to 12 weeks

 

Baseline

12 weeks

Baseline

12 weeks

M (SE)

M (SE)

M (SE)

M (SE)

M (SE)

95% CI [LCI, UCI]

t a

df

p

Symptoms

 MADRS (0-60)

26.1 (1.0)

14.8 (1.1)

24.7 (1.0)

20.5 (1.2)

7.1 (1.6)

3.9, 10.4

4.38

60.7

<.001

 HADS – (D) (0-21)

10.0 (0.6)

5.3 (0.7)

9.2 (0.6)

6.8 (0.7)

2.3 (1.1)

0.2, 4.4

2.20

55.1

.032

 HADS – (A) (0-21)

12.1 (0.6)

8.4 (0.6)

11.2 (0.6)

9.5 (0.7)

2.0 (0.9)

0.2, 3.9

2.19

59.0

.033

Mood

 POMS (-32–200)

54.5 (6.0)

30.3 (6.5)

40.9 (5.8)

32.1 (6.7)

15.4 (9.9)

-4.6, 35.3

1.56

43.5

.127

Self-efficacy

 GSE (10-40)

24.6 (1.0)

28.1 (1.0)

25.7 (1.0)

26.7 (1.1)

-2.4 (1.6)

-5.7, 0.9

-1.44

59.0

.156

Wellbeing

 WHO-5 (0-25)

6.9 (0.8)

12.3 (0.9)

6.7 (0.8)

10.3 (1.0)

-1.8 (1.7)

-5.2, 1.6

-1.04

62.0

.304

Anthropometry

 BMI

30.0 (1.4)

29.9 (1.4)

29.0 (1.4)

29.1 (1.4)

0.15 (0.27)

-0.4, 0.7

0.56

47.0

.579

 Physical activity (IPAQ scores)

2307.7 (664.8)

2251.3 (645.9)

2509.4 (636.3)

2892.2 (636.3)

439.3 (1097.6)

-1757.2, 2635

0.40

58.9

.690

Diet

 ModiMedDiet (0-120)

36.2 (2.5)

55.1 (2.8)

47.3 (2.6)

45.4 (2.9)

-20.7 (4.3)

-20.7, -12.1

-4.78

55.62

<.001

Biomarkers

 Glucose (mmol/L)

4.5 (0.5)

4.7 (5.5)

5.4 (0.5)

5.5 (0.6)

-0.1 (4.3)

-0.9, 0.8

-0.10

48.5

.919

 Cholesterol (mmol/L)

4.9 (0.2)

4.8 (0.2)

5.5 (0.2)

5.2 (0.2)

-0.2 (0.2)

-0.5, 0.2

-1.08

47.7

.287

Triglycerides (mmol/L)

1.3 (0.2)

1.2 (0.2)

1.4 (0.2)

1.5 (0.2)

0.2 (0.2)

-0.3, 0.7

0.88

53.4

.386

 HDL cholesterol (mmol/L)

-1.5 (0.1)

1.5 (0.1)

1.4 (0.1)

1.3 (0.1)

-0.1 (0.1)

-0.2, 0.1

-1.11

47.7

.272

 LDL cholesterol (mmol/L)

2.9 (0.2)

2.8 (0.1)

3.4 (0.2)

3.2 (0.2)

-0.1 (0.2)

-0.4, 0.3

-0.48

47.1

.636

 Total saturates (% FA)

35.7 (0.5)

36.6 (0.5)

35.6 (0.5)

38.1 (0.6)

1.6 (1.0)

-0.5, 3.6

1.54

62.1

.128

 Total monounsaturates (% FA)

23.2 (0.4)

22.2 (0.5)

22.8 (0.4)

23.2 (0.6)

1.4 (0.8)

-0.3, 3.1

1.69

55.4

.096

 Total polyunsaturates (% FA)

41.1 (0.7)

41.3 (0.8)

41.6 (0.7)

38.6 (0.9)

-3.1 (1.3)

-5.7, 0.5

-2.41

54.9

.019

 n6 (% PUFA)

14.6 (0.4)

14.5 (0.4)

14.3 (0.4)

12.8 (0.5)

-1.4 (0.8)

-3.0, 0.3

-1.69

62.1

.096

 n3 (% PUFA)

6.9 (0.3)

6.8 (0.3)

6.5 (0.3)

7.2 (0.4)

0.9 (0.6)

-0.3, 2.1

1.57

57.8

.123

  1. MADRS Montgomery-Åsberg Depression Rating Scale, HADS Hospital Anxiety and Depression Scale, POMS Profile of Mood States, GSE Generalized Self-Efficacy scale, WHO-5 WHO (Five) wellbeing index, BMI body mass index, FA fatty acids, PUFA polyunsaturated fatty acids
  2. aDerived from planned comparison within mixed model repeated measures (MMRM) using all available data (baseline data n = 67, 12 week data n = 56) and based on unadjusted estimates